Dual spatial maps of transcript and protein abundance in the mouse brain

Expert Review of Proteomics

Volumn 6, Issue 3, 2009, Pages 243-249

  Park, Christopher C ^a   Petyuk, Vladislav A ^b   Qian, Wei Jun ^b   Smith, Richard D ^b   Smith, Desmond J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

Author keywords

Brain mapping; In situ hybridization; Mass spectrometry; Microarray; Mouse model; Neurodegeneration; Parkinson's disease; Proteomics; Transcriptomic; Voxelation

Indexed keywords

BRAIN PROTEIN; MESSENGER RNA;

ARTICLE; BRAIN MAPPING; BRAIN REGION; CODON USAGE; ELECTROSPRAY; GENE EXPRESSION; HIGH THROUGHPUT SCREENING; ION CYCLOTRON RESONANCE MASS SPECTROMETRY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; NONHUMAN; PARKINSON DISEASE; PROTEIN LOCALIZATION; PROTEOMICS; QUANTITATIVE STUDY; TRANSCRIPTOMICS;

ANIMALS; BRAIN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MICE; PROTEINS; PROTEOMICS; RNA, MESSENGER;

EID: 66949115363     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.09.46     Document Type: Article

References (18)

1. Lein ES, Hawrylycz MJ, Ao N et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445(7124), 168-176 (2007). (Pubitemid 46095716)
2. Gong S, Zheng C, Doughty ML et al. A gene expression atlas of the central nervous system based on bacterial artificial chromosomes. Nature 425(6961), 917-925 (2003). • Complete in situ hybridization atlas of all genes in the mouse brain.
3. Meng F, Forbes AJ, Miller LM, Kelleher NL. Detection and localization of protein modifications by high resolution tandem mass spectrometry. Mass Spectrom. Rev. 24(2), 126-134 (2005). (Pubitemid 40325546)
4. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM. Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat. Med. 7(4), 493-496 (2001). • Use of MALDI to create 2D protein-abundance maps from brainsections. (Pubitemid 32298555)
5. Schwartz SA, Weil RJ, Thompson RC et al. Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res. 65(17), 7674-7681 (2005). (Pubitemid 41297241)
6. Peschke M, Verkerk UH, Kebarle P. Features of the ESI mechanism that affect the observation of multiply charged noncovalent protein complexes and the determination of the association constant by the titration method. J. Am. Soc. Mass Spectrom. 15(10), 1424-1434 (2004). (Pubitemid 39311693)
7. Schubert W, Bonnekoh B, Pommer AJ et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat. Biotechnol. 24(10), 1270-1278 (2006). (Pubitemid 44564774)
8. Chin MH, Geng AB, Khan AH et al. A genome-scale map of expression for a mouse brain section obtained using voxelation. Physiol. Genomics 30(3), 313-321 (2007). (Pubitemid 47296190)
9. Petyuk VA, Qian WJ, Chin MH et al. Spatial mapping of protein abundances in the mouse brain by voxelation integrated with high-throughput liquid chromatography-mass spectrometry. Genome Res. 17(3), 328-336 (2007). •• Voxelation maps of proteins for a coronal section of the mouse brain at 1-mm resolution. (Pubitemid 46376742)
10. Qian WJ, Camp DG 2nd, Smith RD. High-throughput proteomics using Fourier transform ion cyclotron resonance mass spectrometry. Expert Rev. Proteomics 1(1), 87-95 (2004).
11. Benjamini Y, Hochberg Y. Controlling the false-discovery rate - a practical and powerful approach to multiple testing. J. R Stat. Soc. Series B 57(1), 289-300 (1995).
12. Bode M, Irmler M, Friedenberger M et al. Interlocking transcriptomics, proteomics and toponomics technologies for brain tissue analysis in murine hippocampus. Proteomics 8(6), 1170-1178 (2008).
13. Irmler M, Hartl D, Schmidt T et al. An approach to handling and interpretation of ambiguous data in transcriptome and proteome comparisons. Proteomics 8(6), 1165-1169 (2008).
14. Chin MH, Qian WJ, Wang H et al. Mitochondrial dysfunction, oxidative stress, and apoptosis revealed by proteomic and transcriptomic analyses of the striata in two mouse models of Parkinson's disease. J. Proteome Res. 7(2), 666-677 (2008). •• Combined transcriptome and proteome analysis of the striatum in a Parkinson's disease model. (Pubitemid 351294029)
15. Jackson-Lewis V, Przedborski S. Protocol for the MPTP mouse model of Parkinson's disease. Nat. Protoc. 2(1), 141-151 (2007). (Pubitemid 47044700)
16. Sonsalla PK, Jochnowitz ND, Zeevalk GD, Oostveen JA, Hall ED. Treatment of mice with methamphetamine produces cell loss in the substantia nigra. Brain Res. 738(1), 172-175 (1996).
17. Qian WJ, Jacobs JM, Camp DG 2nd et al. Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 5(2), 572-584 (2005). (Pubitemid 40262074)
18. 't Hoen PA, Ariyurek Y, Thygesen HH et al. Deep sequencing-based expression analysis shows major advances in robustness, resolution and inter-lab portability over five microarray platforms. Nucleic Acids Res. 36(21), e141 (2008).